DGAP-News: Celesio AG / Key word(s): Change of Personnel
Celesio AG: Markus Pinger to become new CEO of Celesio
23.06.2011 / 13:11
---------------------------------------------------------------------
Markus Pinger to become new CEO of Celesio
*Beiersdorf manager appointed by Supervisory Board, effective 15 August
2011
*Many years of experience in the business of over-the-counter medical
products as well as in dealing with customers from retail, industry and
trade
Stuttgart, 23 June 2011. At today's meeting, the Supervisory Board of
Celesio AG has appointed Markus Pinger, until now member of the management
board at Beiersdorf AG, as new Chairman of the Management Board and CEO of
the company. Markus Pinger will assume his new responsibility as of 15
August 2011. The previous Chairman of the Management Board and CEO of
Celesio, Dr Fritz Oesterle, will leave the company with effect from 30 June
2011. Wolfgang Mähr, member of Celesio AG's Management Board, will act as
Interim Chairman of the Management Board during the transition period from
1 July 2011 to 15 August 2011.
During the past six years, Markus Pinger held several key roles in
Beiersdorf's management board. Most recently, he was responsible for the
'Brands & Supply Chain' business. As part of this capacity, he was
responsible for all product-related segments of brands such as Nivea,
Eucerin and Hansaplast - from research and development to production,
logistics, purchasing, quality management and marketing.
In his sixteen-year career at Beiersdorf AG, Markus Pinger managed to put
the North America business back on track for growth, established the
activities in Northern Europe and the Baltic states, formed a joint venture
for the advanced wound care business directed at doctors and hospitals, and
reorganised Beiersdorf's supply chain management.
Press contact:
Dr Jens Schreiber, Celesio AG, +49 (0)711.5001-380
media@celesio.com
Rainer Berghausen, Celesio AG, +49 (0)711.5001-549
media@celesio.com
About Celesio Group:
Celesio is one of the leading international service providers within the
pharmaceutical and healthcare markets. We are active in 27 countries
worldwide and employ more than 47,000 employees in our three divisions
Patient and Consumer Solutions, Pharmacy Solutions and Manufacturer
Solutions. Approximately 2,300 of Celesio's own retail pharmacies, as part
of Patient and Consumer Solutions, serve over 550,000 customers every day.
In our wholesale activities, the core business of Pharmacy Solutions,
around 130 wholesale branches deliver to more than 65,000 pharmacies - day
in, day out. In the Manufacturer Solutions division, we offer
pharmaceutical manufacturers logistics, marketing and sales solutions and
operate in the area of Efficient Care Pharma.
End of Corporate News
---------------------------------------------------------------------
23.06.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Deutschland
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-736
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
129557 23.06.2011
DGAP-News: Celesio AG: Markus Pinger to become new CEO of Celesio
| Source: EQS Group AG